More than 85% of cancer patients developed COVID-19 antibodies after a second dose of Pfizer

After two doses of Pfizer's COVID-19 vaccine, cancer patients are likely to be protected against the virus. In an Israeli study, 86% of patients tested positive for Covid antibodies after two shots.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news